Titan Pharmaceuticals Inc. has entered into a merger agreement with BSKE Ltd. and KE Sdn. Bhd., where BSKE will acquire Titan and the Company, with existing Titan shareholders expected to own approximately 13.3% of the new entity's shares.
AI Assistant
TITAN PHARMACEUTICALS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.